|

Commensal Bacteria Strains Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Commensal Consortium, Lyophilized live commensal bacterial strains (Live Biotherapeutic Product)

Pipeline

Phase 1: 1

Top Sponsors

  • University of Chicago1

Indications

  • Liver Disease1
  • Liver Failure1
  • Cirrhosis, Liver1
  • Liver Diseases1

Chicago, Illinois1 trial

The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial

The University of Chicago Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.